Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029607

Chief Business Officer sold 2,434 shares at $25.85 ($62,919)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

McNeill Jonathan · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-07 Sale : show line 1 in the form 10b5-1 −2,434 $25.85 $62,919 141,184 D
Open-market sales · 2,434 sh · avg $25.85 · $62,919
Loading xslF345X05/ownership.xml…